Dr. Murthy is Chief Scientific Officer and a founding member of Exela since its inception in 2005. He is a member of the Exela Leadership Team.
Murthy’s scientific accomplishments include developing more than 175 formulations encompassing oral solids, injectables, ophthalmics, otics and topicals, also including a number of injectable NDA(b)(2) and ANDA formulations currently on the U. S. market.
Prior to joining Exela, Murthy served as Chief of Research & Development and Manufacturing at Medreich Ltd. and at TTK Healthcare Ltd, both leading pharmaceutical companies in India.
Murthy holds a Ph.D. in Pharmaceutical Chemistry from Andhra University, India.